Science, Technology & Human Values

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abraham, J.
Right arrow Articles by Sheppard, J.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Science, Technology & Human Values, Vol. 22, No. 2, 139-167 (1997)
DOI: 10.1177/016224399702200201

Democracy, Technocracy, and the Secret State of Medicines Control: Expert and Nonexpert Perspectives

John Abraham

University of Sussex

Julie Sheppard

Genetics Forum, London

This article explores the social frameworks guiding expert and nonexpert perspectives on medicines safety in the U.K. Scientific experts from the Committee on the Safety of Medicines and the Medicines Commission were interviewed, and three nonexpertgroups, including patients and health professionals, were studied by the administration of questionnaires and focused group discussions. The research examined to what extent these groups subscribed to technocratic or democratic approaches to medicines regula tion and how this might be related to values toward technological risk. The results reveal that there is substantial divergence between expert and nonexpert perspectives on medicines regulation, and that this derives as much from value differences as from any informational deficits. However, there seems to be some scope for shared values between some experts and some nonexperts, especially as regards state secrecy. The article concludes by discussing how those values could be used to foster a new "social contract of expertise" in which scientists are more democratically accountable and patients take more responsibility in governing medical risks.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Public Adm Res TheoryHome page
C. Jewell and L. Bero
Public Participation and Claimsmaking: Evidence Utilization and Divergent Policy Frames in California's Ergonomics Rulemaking
J. Public Adm. Res. Theory., October 1, 2007; 17(4): 625 - 650.
[Abstract] [Full Text] [PDF]


Home page
Science Technology Human ValuesHome page
J. Abraham and C. Davis
Deficits, Expectations and Paradigms in British and American Drug Safety Assessments: Prising Open the Black Box of Regulatory Science
Science Technology Human Values, July 1, 2007; 32(4): 399 - 431.
[Abstract] [PDF]


Home page
SociologyHome page
J. Abraham and G. Lewis
Citizenship, Medical Expertise and the Capitalist Regulatory State in Europe
Sociology, February 1, 2002; 36(1): 67 - 88.
[Abstract] [PDF]